Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tech News St. Vincent & Grenadines.
Press releases published on October 22, 2025
Revolution Medicines to Present Updated Elironrasib Safety and Efficacy Data in Patients with KRAS G12C Non-Small Cell Lung Cancer Following Treatment with a KRAS(OFF) G12C Inhibitor
REDWOOD CITY, Calif., Oct. 22, 2025 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a late-stage clinical oncology company developing targeted therapies for patients with RAS-addicted cancers, today announced updated clinical data for …
Frontier Medicines Presents Preclinical Data from Three Programs at the 37th AACR-NCI-EORTC International Conference on Molecular Targets
– FMC-376 demonstrated robust anti-tumor activity across preclinical models and led to deeper inhibition of KRAS downstream pathways compared to sotorasib – – FMC-220 potently and selectively restored p53 tumor suppressor function and delivered tumor …
Ainekko Launches AI Foundry, Bringing Open-Source Principles and ‘Do-Ocracy’ to AI Hardware
SANTA CLARA, Calif., Oct. 22, 2025 (GLOBE NEWSWIRE) -- (RISC-V Summit) — Ainekko, a startup pioneering open, software-defined AI infrastructure, today made public the launch of AI Foundry, an open-source platform designed to make advanced hardware and …
Assembly Software Achieves SOC 2 Type II Compliance, Demonstrating Unmatched Commitment to Data Security and Trust
CORAL GABLES, Fla., Oct. 22, 2025 (GLOBE NEWSWIRE) -- Assembly Software, a leading provider of AI-powered legal technology and cloud-based solutions, today announced SOC 2 Type II compliance for its Neos platform and NeosAI services, following a …
AACR Abstract: First Evidence that Selective A2B Receptor Inhibition Lowers PD-L1 Tumor Expression and also Directly Suppresses Mesothelioma Tumor Growth
Dover, DE, Oct. 22, 2025 (GLOBE NEWSWIRE) -- AlphaTON Capital Corp (Nasdaq: ATON) and its oncology-focused subsidiary Tarus Therapeutics, LLC, operating as Cyncado Therapeutics, announce that the AACR has published online the company’s abstract for …
Darktrace Celebrates Unsung Cybersecurity Heroes with Support of Actor, Writer and Director Clark Gregg
Cambridge, UK, Oct. 22, 2025 (GLOBE NEWSWIRE) -- Darktrace, a global leader in AI for cybersecurity, today launched the next phase of its global ‘Defend Beyond™’ campaign in partnership with actor Clark Gregg to celebrate the unseen heroes safeguarding the …
Hemophilia Specialists Raise the Bar: Quality of Life and Innovation Drive Market Reordering
EXTON, PA, Oct. 22, 2025 (GLOBE NEWSWIRE) -- Hematologists across the United States are redefining what “success” looks like in hemophilia treatment, according to the latest findings from Market Dynamix™: Hemophilia (US) 2025 and the accompanying Launch …
AI-powered Co-parenting App BestInterest Launches Solo Mode with Calling — the First AI-Powered Co-Parenting App Offering Safe Digital Separation for High-Conflict Parents
San Francisco, CA , Oct. 22, 2025 (GLOBE NEWSWIRE) -- BestInterest, the pioneering AI-powered co-parenting app for safer communication, has unveiled its latest breakthrough feature, Solo Mode with Calling. This innovative addition empowers parents to …
La planta de productos farmacéuticos estériles de Curia es nombrada “Fabricante del Año” en Massachusetts
ALBANY, Nueva York, Oct. 22, 2025 (GLOBE NEWSWIRE) -- Curia Global, Inc. (Curia), una organización líder en investigación, desarrollo y fabricación por contrato (CDMO), anunció hoy que su planta de productos farmacéuticos estériles en Burlington, MA ha …
Curias Anlage für sterile Arzneimittel als Hersteller des Jahres in Massachusetts ausgezeichnet
ALBANY, N.Y., Oct. 22, 2025 (GLOBE NEWSWIRE) -- Curia Global, Inc. (Curia), ein führendes Auftragsforschungs-, Entwicklungs- und Produktionsunternehmen, gab heute bekannt, dass seine Anlage für sterile Arzneimittel in Burlington, Massachusetts, vom …
L'usine de médicaments stériles Curia nommée fabricant de l'année dans le Massachusetts
ALBANY, N.Y., 22 oct. 2025 (GLOBE NEWSWIRE) -- Curia Global, Inc. (Curia), une organisation leader dans la recherche, le développement et la fabrication sous contrat, a annoncé aujourd'hui que son usine de produits pharmaceutiques stériles de Burlington, …
מפעל מוצרי התרופות הסטרילי של Curia זכה בתואר יצרן השנה במסצ'וסטס
אולבני, ניו יורק, Oct. 22, 2025 (GLOBE NEWSWIRE) -- Curia Global, Inc. (קוריה), ארגון מוביל למחקר, פיתוח וייצור לפי חוזים, הודיע היום כי מפעל מוצרי התרופות הסטריליות שלו בברלינגטון, מסצ'וסטס זכה בתואר "יצרן השנה" על ידי שדולת הייצור המחוקקת של מסצ'וסטס. …
Fasilitas Produk Obat Steril Curia Dinobatkan sebagai Produsen Terbaik Tahun Ini di Massachusetts
ALBANY, N.Y., Oct. 22, 2025 (GLOBE NEWSWIRE) -- Curia Global, Inc. (Curia), perusahaan penelitian, pengembangan, dan manufaktur terkemuka berbasis kontrak hari ini mengumumkan bahwa fasilitas produksi obat sterilnya di Burlington, Massachusetts, telah …
Curia (큐리아) 멸균 의약품 생산시설, 매사추세츠주 ‘올해의 제조업체(Manufacturer of the Year)’ 선정
뉴욕주 올버니, Oct. 23, 2025 (GLOBE NEWSWIRE) -- Curia Global, Inc.(큐리아)는 오늘 매사추세츠주 벌링턴에 위치한 자사의 멸균 의약품 생산 시설이 매사추세츠 주 의회 제조업 코커스(Massachusetts Legislative Manufacturing Caucus) 로부터 ‘올해의 제조업체 (Manufacturer of the Year)’로 선정되었다고 발표했다. 이 상은 10월 21일 질레트 스타디움( …
Fasiliti Produk Ubat Steril Curia Dinobatkan sebagai Pengilang Terbaik Massachusetts Tahun Ini
ALBANY, N.Y., Oct. 22, 2025 (GLOBE NEWSWIRE) -- Curia Global, Inc. (Curia), sebuah organisasi terkemuka dalam penyelidikan kontrak, pembangunan dan pembuatan, hari ini mengumumkan bahawa fasiliti produk ubat sterilnya di Burlington, Massachusetts telah …
Instalação de Medicamentos Estéreis da Curia Nomeada Fabricante do Ano de Massachusetts
ALBANY, N.Y., Oct. 22, 2025 (GLOBE NEWSWIRE) -- A Curia Global, Inc. (Curia), uma organização líder em contratos de pesquisa, desenvolvimento e fabricação, anunciou hoje que sua instalação de medicamentos estéreis em Burlington, MA, foi nomeada "Fabricante …
โรงงานผลิตภัณฑ์ยาปลอดเชื้อ Curia ได้รับการเสนอชื่อให้เป็นผู้ผลิตแห่งปีของรัฐแมสซาชูเซตส์
ออลบานี รัฐนิวยอร์ก, Oct. 22, 2025 (GLOBE NEWSWIRE) -- Curia Global, Inc. (Curia) ซึ่งเป็นองค์กรชั้นนำด้านการวิจัย พัฒนา และการผลิตตามสัญญา ได้ประกาศในวันนี้ว่าโรงงานผลิตภัณฑ์ยาปลอดเชื้อในเบอร์ลิงตัน รัฐแมสซาชูเซตส์ ได้รับการเสนอชื่อให้เป็น "ผู้ผลิตแห่งปี" …